AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1.
Abou Haidar E, Prabhakar S, Geffrey AL, Mahamdeh M, Tomeh T, Breyne K, Roumieh E, Gurevich M, Soberman RJ, Wojtkiewicz GR, Chen JW, Han JS, Stemmer-Rachamimov A, Breakefield XO.
Abou Haidar E, et al. Among authors: han js.
Mol Ther Methods Clin Dev. 2025 Aug 13;33(3):101556. doi: 10.1016/j.omtm.2025.101556. eCollection 2025 Sep 11.
Mol Ther Methods Clin Dev. 2025.
PMID: 40932991
Free PMC article.